BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2230926
,
MDM2
,
Response to oxidative stress
,
HIV infection
,
Retina
,
Amniocentesis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Abeta)(1-42
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for Abeta)(1-42
Explore Curated Studies Results
Literature
Most Relevant Literature
Development of an Immunoassay for the Detection of Amyloid Beta 1-42 and Its Application in Urine Sa…
Small Oligomers of Aβ42 Protein in the Bulk Solution with AlphaFold2.
Study on molecular mechanisms of destabilizing Aβ(1-42) protofibrils by licochalcone A and licochalc…
Edaravone Attenuates Aβ 1-42-Induced Inflammatory Damage and Ferroptosis in HT22 Cells.
The potential of lumbrokinase and serratiopeptidase for the degradation of Aβ 1-42 peptide - an in v…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Do HMG CoA Reductase Inhibitors Affect Abeta Levels?
Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted …
A Phase 1 Study To Characterize The Safety, Tolerability, PK And PK Of Repeat Doses Of PF-06648671 I…
A Safety and Tolerability Study of JNJ-54861911 in Participants With Early Alzheimer's Disease
Dose-Finding Study To Evaluate the Safety and Tolerability of E2609 in Subjects With Mild Cognitive …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ